> This is incorrect. There are ongoing phase 3 clinical trials for nasally applied esketamine that will lead to FDA approval if succesfully reviewed.
Specifically esketamine, not ketamine, because focusing on this specific isomer was the only way to get a new patent.
What if racemic ketamine performs better than esketamine? We'll never know because they won't test that.